Bohn, Laura M.

Bias factor and therapeutic window correlate to predict safer opioid analgesics

Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell

Receptor Mechanisms and SignalingNeuropeptides and Animal Physiology

Cited by 567

Community guidelines for GPCR ligand bias: IUPHAR review 32

Kolb, P., Kenakin, T., Alexander, S. P. H., Bermudez, M., Bohn, L. M., Breinholt, C. S., Bouvier, M., Hill, S. J., Kostenis, E., Martemyanov, K. A., et al. (2022) · British Journal of Pharmacology

Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

Cited by 232

β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia

Raehal, K. M., & Bohn, L. M. (2014) · Handbook of Experimental Pharmacology

Receptor Mechanisms and SignalingNeuropeptides and Animal Physiology

Cited by 154

Optimization of a series of mu opioid receptor (MOR) agonists with high G protein signaling bias

Kennedy, N. M., Schmid, C. L., Ross, N. C., Lovell, K. M., Yue, Z., Chen, Y. T., Cameron, M. D., Bohn, L. M., & Bannister, T. D. (2018) · Journal of Medicinal Chemistry

Receptor Mechanisms and SignalingNeuropeptides and Animal Physiology

Cited by 71

Recruitment of β-Arrestin into Neuronal Cilia Modulates Somatostatin Receptor Subtype 3 Ciliary Localization

Green, J. A., Schmid, C. L., Bley, E., Monsma, P. C., Brown, A., Bohn, L. M., & Mykytyn, K. (2016) · Molecular and Cellular Biology

Genetic and Kidney Cyst DiseasesReceptor Mechanisms and Signaling

Cited by 67